{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:57Z","timestamp":1707525177786},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,18]]},"DOI":"10.7759\/cureus.43714","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T20:02:40Z","timestamp":1692388960000},"source":"Crossref","is-referenced-by-count":0,"title":["Myxoma Mimic in a Patient With Acute Myeloid Leukemia"],"prefix":"10.7759","author":[{"given":"Natalia","family":"Campo-Rivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oswaldo","family":"Aguilar-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephany","family":"Barbosa-Balaguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1530\/ERP-16-0035","article-title":"Cardiac tumors: echo assessment","volume":"3","author":"Mankad R","year":"2016","unstructured":"Mankad R, Herrmann J. Cardiac tumors: echo assessment. Echo Res Pract. 2016, 3:R65-77. 10.1530\/ERP-16-0035","journal-title":"Echo Res Pract"},{"key":"ref2","article-title":"WHO classification of tumours of the lung, pleura, thymus and heart","year":"2015","unstructured":"WHO classification of tumours of the lung, pleura, thymus and heart. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (ed). World Health Organization, Geneva, Switzerland; 2015."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-020-01420-z","article-title":"Cardiac tumors: diagnosis, prognosis, and treatment","volume":"22","author":"Bussani R","year":"2020","unstructured":"Bussani R, Castrichini M, Restivo L, et al.. Cardiac tumors: diagnosis, prognosis, and treatment. Curr Cardiol Rep. 2020, 22:169. 10.1007\/s11886-020-01420-z","journal-title":"Curr Cardiol Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e3282f88e49","article-title":"Heart and tumors: location, metastasis, clinical manifestations, diagnostic approaches and therapeutic considerations","volume":"9","author":"Ekmektzoglou KA","year":"2008","unstructured":"Ekmektzoglou KA, Samelis GF, Xanthos T. Heart and tumors: location, metastasis, clinical manifestations, diagnostic approaches and therapeutic considerations. J Cardiovasc Med (Hagerstown). 2008, 9:769-77. 10.2459\/JCM.0b013e3282f88e49","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/208929","article-title":"Cardiac tumors","volume":"2011","author":"Paraskevaidis IA","year":"2011","unstructured":"Paraskevaidis IA, Michalakeas CA, Papadopoulos CH, Anastasiou-Nana M. Cardiac tumors. ISRN Oncol. 2011, 2011:208929. 10.5402\/2011\/208929","journal-title":"ISRN Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-306364","article-title":"Cardiac masses and tumours","volume":"102","author":"Basso C","year":"2016","unstructured":"Basso C, Rizzo S, Valente M, Thiene G. Cardiac masses and tumours. Heart. 2016, 102:1230-45. 10.1136\/heartjnl-2014-306364","journal-title":"Heart"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/jcecho.jcecho_14_18","article-title":"Right cardiac chambers' involvement as the first manifestation of recurrent complex karyotype acute myeloid leukemia","volume":"28","author":"Zanetti C","year":"2018","unstructured":"Zanetti C, Inciardi RM, Benedetti F, Rossi A. Right cardiac chambers' involvement as the first manifestation of recurrent complex karyotype acute myeloid leukemia. J Cardiovasc Echogr. 2018, 28:185-8. 10.4103\/jcecho.jcecho_14_18","journal-title":"J Cardiovasc Echogr"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2015.07.007","article-title":"Malignant tumors of the heart","volume":"39","author":"Hudzik B","year":"2015","unstructured":"Hudzik B, Miszalski-Jamka K, Glowacki J, et al.. Malignant tumors of the heart. Cancer Epidemiol. 2015, 39:665-72.","journal-title":"Cancer Epidemiol"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002491","article-title":"Relapsing leukemia infiltrating the heart","volume":"8","author":"De Lazzari M","year":"2015","unstructured":"De Lazzari M, Fedrigo M, Marra MP, et al.. Relapsing leukemia infiltrating the heart. Circ Heart Fail. 2015, 8:1133-4.","journal-title":"Circ Heart Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.05.009","article-title":"Cardiac tumors: JACC cardiooncology state-of-the-art review","volume":"2","author":"Tyebally S","year":"2020","unstructured":"Tyebally S, Chen D, Bhattacharyya S, et al.. Cardiac tumors: JACC cardiooncology state-of-the-art review. JACC CardioOncol. 2020, 2:293-311. 10.1016\/j.jaccao.2020.05.009","journal-title":"JACC CardioOncol"},{"key":"ref11","article-title":"Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive [Article in Chinese]","volume":"49","author":"Duan WB","year":"2017","unstructured":"Duan WB, Gong LZ, Jia JS, et al.. Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive [Article in Chinese]. Beijing Da Xue Xue Bao Yi Xue Ban. 2017, 49:990-5.","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-023-01089-w","article-title":"Thrombosis in acute myeloid leukemia: pathogenesis, risk factors and therapeutic challenges","volume":"24","author":"Olivi M","year":"2023","unstructured":"Olivi M, Di Biase F, Lanzarone G, et al.. Thrombosis in acute myeloid leukemia: pathogenesis, risk factors and therapeutic challenges. Curr Treat Options Oncol. 2023, 24:693-710. 10.1007\/s11864-023-01089-w","journal-title":"Curr Treat Options Oncol"},{"key":"ref13","article-title":"A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center","volume":"4","author":"Vu K","year":"2015","unstructured":"Vu K, Luong NV, Hubbard J, et al.. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center. Cancer Med. 2015, 4:27-35.","journal-title":"Cancer Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.08.021","article-title":"Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation","volume":"152","author":"Srichai MB","year":"2006","unstructured":"Srichai MB, Junor C, Rodriguez LL, et al.. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006, 152:75-84. 10.1016\/j.ahj.2005.08.021","journal-title":"Am Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.03.041","article-title":"Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction","volume":"52","author":"Weinsaft JW","year":"2008","unstructured":"Weinsaft JW, Kim HW, Shah DJ, et al.. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol. 2008, 52:148-57. 10.1016\/j.jacc.2008.03.041","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2009.03.017","article-title":"Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus","volume":"2","author":"Weinsaft JW","year":"2009","unstructured":"Weinsaft JW, Kim RJ, Ross M, et al.. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovasc Imaging. 2009, 2:969-79. 10.1016\/j.jcmg.2009.03.017","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1136\/heart.89.7.726","article-title":"Right atrial thrombus following closure of an atrial septal defect","volume":"89","author":"Yilmaz M","year":"2003","unstructured":"Yilmaz M, Gurlertop Y, Erdogan F. Right atrial thrombus following closure of an atrial septal defect. Heart. 2003, 89:726.","journal-title":"Heart"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/751507","article-title":"Catheter-related right atrial thrombus and pulmonary embolism: a case report and systematic review of the literature","volume":"16","author":"Burns KE","year":"2009","unstructured":"Burns KE, McLaren A. Catheter-related right atrial thrombus and pulmonary embolism: a case report and systematic review of the literature. Can Respir J. 2009, 16:163-5. 10.1155\/2009\/751507","journal-title":"Can Respir J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi130","article-title":"Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies","volume":"26","author":"Ogren M","year":"2005","unstructured":"Ogren M, Bergqvist D, Eriksson H, Lindblad B, Sternby NH. Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies. Eur Heart J. 2005, 26:1108-14. 10.1093\/eurheartj\/ehi130","journal-title":"Eur Heart J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian A","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al.. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022, 43:561-632. 10.1093\/eurheartj\/ehab395","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/177275-myxoma-mimic-in-a-patient-with-acute-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:11Z","timestamp":1707509051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/177275-myxoma-mimic-in-a-patient-with-acute-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.43714","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,18]]}}}